Subhdeep Virk, MD

  • 7Articles
  • 13.3KReads1
  • 2000–2025Active
  • 21Collaborators
  • 41Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Subhdeep Virk, MD, is affiliated with the Depression Recovery Center, Department of Psychiatry and Behavioral Health at The Ohio State University Wexner Medical Center and College of Medicine in Columbus, Ohio. Virk has published extensively on topics including treatment-resistant depression, bipolar disorder, dementia-related behavioral disturbances, and the psychiatric aspects of gastroenterology and neurology. The work includes studies on pharmacologic treatments such as citalopram and paroxetine for irritable bowel syndrome, comparisons of antipsychotics in mood disorders, and the use of acetylcholinesterase inhibitors in dementia. Virk’s publications span from 2000 to 2025 and frequently involve collaboration with co-authors such as Prakash S. Masand and Sanjay Gupta.

Publications

JCP
Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment
Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment

May 7, 2025

Consensus recommendations about the goals of a consultation for treatment-resistant depression include establishing the primary diagnosis and comorbidities, clarifying symptoms, identifying goals, documenting treatment history, identifying treatment barriers, and...
, , , et al
JCP
Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations
Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

April 28, 2025

Key practical considerations are described, including systems-level and financial issues; equity and access to TRD care for a diverse population; selecting a target population and facilitating referrals; communication between...
, , , et al
PCC
Original Research

Open-Label Treatment With Citalopram in Patients With Irritable Bowel Syndrome: A Pilot Study

August 15, 2005

, , , et al
JCP
Letter to the Editor

Urinary Incontinence With Mirtazapine

May 12, 2002

, ,
PCC
Original Research

Comparison of Risperidone and Olanzapine in Bipolar and Schizoaffective Disorders

April 1, 2002

, , , et al
PCC
Original Research

Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study

February 1, 2002

, , , et al
PCC
Letter to the Editor

Acetylcholinesterase Inhibitors: Treatment of Dementia-Related Behavioral Disturbances

December 1, 2000

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe